Delivery Order 36F79723D0188-70FA4024F00000271
Award Date 5/20/24
Potential Completion Date 5/31/24
Potential Value $16K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20472, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the purchase of NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The award is for a Firm Fixed Price contract with a ceiling value of $18,995.76 and a completion date of June 1, 2024. Emergent Devices is a subsidiary of Emergent BioSolutions and is a key supplier of naloxone products to various...
- The U.S. government agency, Office of Procurement Operations, awarded a $66,870.72 firm fixed-price delivery order contract to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the supply of NALOXONE (NARCAN) NASAL SPRAY 4MG MEDICATION. The contract has an ultimate completion date of June 12, 2025. Emergent Devices holds multiple federal contracts and grant sub-awards to supply NARCAN nasal spray and other naloxone formulations to various government agencies, including the...
- This is a firm-fixed price delivery order awarded by the Department of Justice Bureau of Prisons Federal Correctional Institution Ashland to Emergent Devices, Inc. (also known as Emergent BioSolutions), a for-profit manufacturer, for the supply of NARCAN (naloxone nasal spray). The order, valued at $1,356.84, is being awarded under Emergent Devices' Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and has an expected completion date of October 31, 2024. This contract...
- This federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, is for the provision of pharmaceuticals, specifically NARCAN nasal spray and other naloxone products, to various U.S. government agencies. The $226,140.00 Firm Fixed Price delivery order was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 and has a completion date of January 13, 2017. Emergent Devices holds two significant federal contract vehicles - an $11.8...
- This is a federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, by the Department of Veterans Affairs (VA). The contract is for the delivery of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has a ceiling value of $226,140.00 and an ultimate completion date of December 16, 2016. This appears to be a delivery order placed under Emergent Devices' $11.8 million multiple-award Federal Supply Schedule contract with...
- This is a federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, by the Department of Veterans Affairs for NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has a ceiling value of $130,256.64 and is a Firm Fixed Price Delivery Order. It is not a set-aside contract. Emergent Devices, Inc. is a subsidiary of Emergent BioSolutions, a multinational specialty biopharmaceutical company. The company holds multiple...
- This is a $1,696.00 firm-fixed price delivery order awarded to Emergent Devices, Inc. by the Federal Correctional Institution Ashland, a civilian agency, under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. The order is for NARCAN, an opioid overdose reversal medication. This delivery order supports the agency's healthcare, law enforcement, and public safety missions by providing access to critical overdose prevention and harm reduction resources. Emergent Devices,...
- This is a $686,400.00 Delivery Order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceutical goods. The contract is part of the VA's Federal Supply Schedule 65 IB for Pharmaceuticals and Drugs, which allows the agency to purchase naloxone nasal spray and other hematology-related products from Emergent Devices through August 2028. Emergent Devices has also received sub-awards from state health...
- This is a $455,898.24 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Emergent Devices, Inc., a pharmaceutical manufacturer, for the supply of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has an ultimate completion date of August 17, 2016 and was awarded on August 10, 2016 without any set-aside designation. Emergent Devices, a subsidiary of Emergent BioSolutions, is a key supplier of naloxone...
- The Department of Veterans Affairs Veterans Health Administration awarded a $904,465.44 firm fixed price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, holds a Federal Supply Schedule 65 IB contract to provide pharmaceuticals and drugs to VA facilities through 2028. This delivery order was placed against that larger contract...